| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0025-6196(12)61204-X |
| P698 | PubMed publication ID | 1907344 |
| P2093 | author name string | Z M Ruggeri | |
| P2860 | cites work | Evidence that the primary binding site of von Willebrand factor that mediates platelet adhesion on subendothelium is not collagen | Q24292860 |
| Initial glycosylation and acidic pH in the Golgi apparatus are required for multimerization of von Willebrand factor | Q24295998 | ||
| Mutation in the gene encoding the alpha chain of platelet glycoprotein Ib in platelet-type von Willebrand disease | Q24561673 | ||
| Studies on the mechanism of ristocetin-induced platelet agglutination. Effects of structural modification of ristocetin and vancomycin | Q24595238 | ||
| New perspectives in cell adhesion: RGD and integrins | Q28280381 | ||
| Amino acid sequence of human von Willebrand factor | Q28630812 | ||
| The molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GpIb binding domain | Q28776603 | ||
| Molecular basis of von Willebrand disease type IIB. Candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequences | Q28776606 | ||
| Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule | Q29616413 | ||
| von Willebrand's variant (type II Buffalo). Thrombocytopenia after desmopressin but absence of in vitro hypersensitivity to ristocetin | Q33404697 | ||
| Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor | Q33444536 | ||
| Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent | Q33481601 | ||
| Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers | Q33481677 | ||
| Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura | Q33481821 | ||
| Homozygous and heterozygous deletions of the von Willebrand factor gene in patients and carriers of severe von Willebrand disease | Q33567446 | ||
| Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor | Q33749366 | ||
| Platelets have more than one binding site for von Willebrand factor | Q33821754 | ||
| Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA. | Q33857871 | ||
| The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress | Q34182746 | ||
| Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa | Q34260216 | ||
| Prevention of occlusive coronary artery thrombosis by a murine monoclonal antibody to porcine von Willebrand factor | Q34366855 | ||
| Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE). | Q34528381 | ||
| Biosynthesis of von Willebrand protein by human megakaryocytes | Q34554462 | ||
| Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate | Q34564820 | ||
| von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia | Q34574601 | ||
| Venom coagglutinin: an activator of platelet aggregation dependent on von Willebrand factor | Q35991709 | ||
| Biosynthesis of von Willebrand protein by human endothelial cells: processing steps and their intracellular localization | Q36212119 | ||
| Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC) | Q36988093 | ||
| An explanation for minor multimer species in endothelial cell-synthesized von Willebrand factor | Q36994972 | ||
| Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets | Q37023086 | ||
| Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease | Q37046074 | ||
| Investigation of a kindred with a new autosomal dominantly inherited variant type von Willebrand's disease (possible type IID). | Q37192691 | ||
| Identification of a point mutation in type IIB von Willebrand disease illustrating the regulation of von Willebrand factor affinity for the platelet membrane glycoprotein Ib-IX receptor | Q37470139 | ||
| In vitro correction of the abnormal multimeric structure of von Willebrand factor in type IIa von Willebrand's disease | Q37531782 | ||
| von Willebrand factor biosynthesis and processing | Q37711742 | ||
| Nucleotide sequence of pre-pro-von Willebrand factor cDNA. | Q40418506 | ||
| Gene deletions correlate with the development of alloantibodies in von Willebrand disease | Q40922128 | ||
| Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction | Q44468499 | ||
| Functional modulation of the isolated glycoprotein Ib binding domain of von Willebrand factor expressed in Escherichia coli | Q44699205 | ||
| Type II H von Willebrand disease: new structural abnormality of plasma and platelet von Willebrand factor in a patient with prolonged bleeding time and borderline levels of ristocetin cofactor activity | Q44880774 | ||
| Binding of von Willebrand factor to glycoproteins Ib and IIb/IIIa complex: affinity is related to multimeric size | Q45884940 | ||
| Propolypeptide of von Willebrand factor circulates in blood and is identical to von Willebrand antigen II | Q56459904 | ||
| von Willebrand disease type IIC with different abnormalities of von Willebrand factor in the same sibship | Q68792876 | ||
| Multimeric pattern discrepancy between platelet and plasma von Willebrand factor in type IIC von Willebrand disease | Q68794895 | ||
| Heterogeneity in type IIB von Willebrand disease: two unrelated cases with no family history and mild abnormalities of ristocetin-induced interaction between von Willebrand factor and platelets | Q68810483 | ||
| A variant of type II von Willebrand disease with an abnormal triplet structure and discordant effects of protease inhibitors on plasma and platelet von Willebrand factor structure | Q68816172 | ||
| Investigation of a case of subtype IIC von Willebrand disease: characterization of the variability of this subtype | Q70291513 | ||
| Von Willebrand factor multimer patterns in von Willebrand's disease | Q70454272 | ||
| Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease | Q71498185 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 847-861 | |
| P577 | publication date | 1991-08-01 | |
| P1433 | published in | Mayo Clin Proc | Q6538184 |
| P1476 | title | Structure and function of von Willebrand factor: relationship to von Willebrand's disease | |
| P478 | volume | 66 |
| Q33968288 | A conformation-sensitive monoclonal antibody against the A2 domain of von Willebrand factor reduces its proteolysis by ADAMTS13 |
| Q45866539 | A monoclonal antibody (B724) to von Willebrand factor recognizing an epitope within the A1 disulphide loop (Cys509-Cys695) discriminates between type 2A and type 2B von Willebrand disease |
| Q40579954 | A new flow cytometric method for measurement of von Willebrand factor activity |
| Q47287083 | A novel type 2A (Group II) von Willebrand disease mutation (L1503Q) associated with loss of the highest molecular weight von Willebrand factor multimers |
| Q38380070 | ABO blood groups in relation to breast carcinoma incidence and associated prognostic factors in Moroccan women |
| Q45886373 | Appendix II: A revised classification of Von Willebrand disease*: For The Subcommittee on Von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis |
| Q34466077 | Evaluation of von Willebrand factor and von Willebrand factor propeptide in models of vascular endothelial cell activation, perturbation, and/or injury |
| Q36925330 | Functional analysis of a type IIB von Willebrand disease missense mutation: increased binding of large von Willebrand factor multimers to platelets |
| Q30811796 | Labelling of rat endothelial cells with antibodies to vWF, RECA-1, PECAM-1, ICAM-1, OX-43 and ZO-1. |
| Q40519731 | New variant of type II von Willebrand's disease with structural abnormality of plasma von Willebrand factor in a patient with very mild bleeding history |
| Q35010760 | Plasma von Willebrand factor level as a prognostic indicator of patients with metastatic colorectal carcinoma |
| Q41040556 | Proteolytic processing of von Willebrand factor subunit: heterogeneity in type-IIA von Willebrand disease |
| Q33740244 | Recombinant von Willebrand factor: potential therapeutic use. |
| Q38880592 | The clinical value of von Willebrand factor in colorectal carcinomas. |
| Q40817282 | The pathologist as a clinical consultant for hemostasis in the community hospital. |
| Q47766336 | Type III von Willebrand's disease in Dutch kooiker dogs |
Search more.